Creso Pharma (ASX:CPH) shares jump on record revenue growth

• Creso Pharma (CPH) has reported its second consecutive quarter of record revenue growth, reaching just over $1.7 million in the quarter ending June 30
• This is a 24 per cent increase over the last quarter and a 451 per cent increase over the previous corresponding period
• The growth has come from strong demand for Creso's animal and human health CBD products as well as craft cannabis products from its Canadian subsidiary

Read the Full Article on The Market Herald here